UPDATE 1-Gilead's HIV drug gets closer to getting Europe approval
February 26, 2016 at 08:44 AM EST
Feb 26 (Reuters) - Gilead Sciences Inc's experimental cocktail to treat HIV received a green light from European regulators on Friday, boosting the chances of the drug being formally approved by the European Commission.
